Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.38 - $0.58 $170,888 - $260,829
449,706 New
449,706 $175,000
Q2 2021

Aug 16, 2021

SELL
$6.23 - $10.03 $226,485 - $364,630
-36,354 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$8.81 - $16.96 $417,268 - $803,276
-47,363 Reduced 56.58%
36,354 $337,000
Q4 2020

Feb 16, 2021

SELL
$8.5 - $12.85 $267,614 - $404,569
-31,484 Reduced 27.33%
83,717 $741,000
Q3 2020

Nov 16, 2020

BUY
$9.57 - $27.05 $487,907 - $1.38 Million
50,983 Added 79.39%
115,201 $1.34 Million
Q2 2020

Aug 17, 2020

BUY
$7.14 - $31.69 $458,516 - $2.04 Million
64,218 New
64,218 $1.73 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $494M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.